Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADMA: Palbociclib vs Chemotherapy in HR+/HER2- MBC
NCT03355157Phase 4Completed
- Sponsor
- GBG Forschungs
- Start
- Mar 2018
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palbociclib in breast cancer, sponsored by GBG Forschungs. Started Mar 2018; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03355157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355157.